Filing Details
- Accession Number:
- 0001209191-20-026662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-04 07:30:14
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-05-04 07:30:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Aeglea Biotherapeutics Inc. | AGLE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532219 | G. Anthony Quinn | 805 Las Cimas Parkway Suite 100 Austin TX 78746 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-30 | 165,000 | $4.75 | 538,469 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 788 shares acquired by the Reporting Person on August 15, 2019 and 773 shares acquired by the Reporting Person on February 15, 2020 pursuant to the Issuer's employee stock purchase plan.
Billionaire Hedge Funds
